Dr. Rashim Singh research focuses on developing drugs and prebiotic interventions for lowering chronic oxidative stress and inflammation in the intestine and alleviating gut dysbiosis towards preventing drug-induced intestinal toxicities and progression of inflammation-mediated gastrointestinal diseases, such as, colon cancer and inflammatory bowel diseases.